161 related articles for article (PubMed ID: 8777338)
1. [Progesterone receptor in breast cancer: fundamental data and clinical applications].
Ojasoo T
Bull Cancer; 1996; 83 Suppl 1():1-5. PubMed ID: 8777338
[No Abstract] [Full Text] [Related]
2. Estrogen receptor: a never ending story?
Wolff AC; Dowsett M
J Clin Oncol; 2011 Aug; 29(22):2955-8. PubMed ID: 21709205
[No Abstract] [Full Text] [Related]
3. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
Lee JY; Won HY; Park JH; Kim HY; Choi HJ; Shin DH; Kang JH; Woo JK; Oh SH; Son T; Choi JW; Kim S; Kim HY; Yi K; Jang KS; Oh YH; Kong G
J Clin Invest; 2015 May; 125(5):1801-14. PubMed ID: 25822021
[TBL] [Abstract][Full Text] [Related]
4. [Long-term results of adjuvant endocrine therapy for hormone receptor-positive breast cancer].
Semilgazov VF; Manikhas AG; Semiglazov VV; Bozhok AA; Dashian GA; Ivanov VG; Paltuev RM; Vasil'ev AG; Shchedrin DE; Ermachenkova AM; Nikitina IV; Pen'kov KD; Bessonov AA; Tabagua TT; Kolar'kova VV
Vopr Onkol; 2011; 57(5):567-77. PubMed ID: 22238925
[No Abstract] [Full Text] [Related]
5. Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.
van der Flier S; Brinkman A; Look MP; Kok EM; Meijer-van Gelder ME; Klijn JG; Dorssers LC; Foekens JA
J Natl Cancer Inst; 2000 Jan; 92(2):120-7. PubMed ID: 10639513
[TBL] [Abstract][Full Text] [Related]
6. Déjà vu for breast cancer two?
Stearns V; Davidson NE
J Natl Cancer Inst; 2004 Apr; 96(7):497-9. PubMed ID: 15069104
[No Abstract] [Full Text] [Related]
7. A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer.
Bogush EA; Ravcheeva AB; Bogush TA; Zabotina TN; Kadagidze ZG; Davydov MI
Dokl Biochem Biophys; 2007; 413():83-7. PubMed ID: 17546960
[No Abstract] [Full Text] [Related]
8. [Estrogen and progesterone receptors in breast cancer].
Sonoo H
Nihon Rinsho; 2000 Apr; 58 Suppl():146-53. PubMed ID: 11025988
[No Abstract] [Full Text] [Related]
9. [Endocrine therapy for postmenopausal breast cancer (role of cycline D1)].
Manikhas AG; Skvortsov VA; Manikhas GM; Raskin GA; Oganesian AS; Shemerovskiĭ AK
Vopr Onkol; 2011; 57(5):641-4. PubMed ID: 22238936
[No Abstract] [Full Text] [Related]
10. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor testing: not the right time to be buried.
Colozza M; Larsimont D; Piccart MJ
J Clin Oncol; 2005 Jun; 23(16):3867-8; author reply 3869-70. PubMed ID: 15923594
[No Abstract] [Full Text] [Related]
12. Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers.
Osin P; Crook T; Powles T; Peto J; Gusterson B
Lancet; 1998 May; 351(9114):1487. PubMed ID: 9605807
[No Abstract] [Full Text] [Related]
13. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
14. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
15. Changing concepts of hormone receptor-positive advanced breast cancer therapy.
Chlebowski RT
Clin Breast Cancer; 2013 Jun; 13(3):159-66. PubMed ID: 23228361
[No Abstract] [Full Text] [Related]
16. In search of the perfect SERM: beyond tamoxifen and raloxifene.
McNeil C
J Natl Cancer Inst; 1998 Jul; 90(13):956-7. PubMed ID: 9665139
[No Abstract] [Full Text] [Related]
17. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
Jovanović-Mićić D; Beleslin DB; Nikolić SS
Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
[TBL] [Abstract][Full Text] [Related]
18. [Basic Consensus on endocrinotherapy for breast cancer].
Jiang ZF; Xu BH; Song ST
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):238-9. PubMed ID: 16875616
[No Abstract] [Full Text] [Related]
19. [Intracystic papillary carcinoma of the breast: report of three cases].
El mazghi A; Bouhafa T; Loukili K; El kacemi H; Lalya I; Kebdani T; Hassouni K
Pan Afr Med J; 2014; 18():207. PubMed ID: 25419333
[TBL] [Abstract][Full Text] [Related]
20. [Estrogen and progesterone receptors in carcinoma of the breast].
Musiani P; Piantelli M; Dina MA
Pathologica; 1979; 71(1011):1-7. PubMed ID: 450473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
